← Back to Search

Powered Orthosis

Powered KAFO for Mobility Impairments

N/A
Recruiting
Research Sponsored by Shirley Ryan AbilityLab
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Cognitive ability to understand and follow the study protocol; willingness to provide informed consent
Regular and compliant use of a unilateral or bilateral KAFO or SCO or other passive KAFOs for impairment due to neurological or neuromuscular disease, orthopedic disease, or trauma
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during each 3 month home trial with each device.
Awards & highlights

Study Summary

This trial will measure if the Nomad powered KAFO improves mobility, balance, frequency of falls, and quality of life in people who have had a musculoskeletal or neurological injury.

Who is the study for?
This trial is for individuals with conditions like paralysis, muscular dystrophy, or spinal cord injury that affect walking. Participants must regularly use a leg brace due to their condition, be able to follow the study's instructions, and consent to wearing an activity monitor for three months.Check my eligibility
What is being tested?
The Nomad P-KAFO is being tested for its effectiveness in improving mobility and quality of life over three months compared to participants' usual braces. It involves recording daily activities with a sensor and assessing mobility using both the participant's own brace and the Nomad P-KAFO.See study design
What are the potential side effects?
While specific side effects are not listed, potential issues may include discomfort from wearing new orthotic devices, skin irritation at contact points of the device, or muscle fatigue from altered gait patterns during use.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I understand the study details and agree to participate.
Select...
I regularly use a leg brace due to a neurological, muscle, or bone condition.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during each 3 month home trial with each device.
This trial's timeline: 3 weeks for screening, Varies for treatment, and during each 3 month home trial with each device. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in 10 Meter Walk Test speed
Secondary outcome measures
Activities Specific Balance Confidence Scale
Berg Balance Test
Borg Rate of Perceived Exertion
+13 more
Other outcome measures
Community Mobility
Cross Walk Blinking Signal Test
Self Reported Goals

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Group AExperimental Treatment1 Intervention
Group A receives the intervention Nomad KAFO first; fitting & training will occur with the intervention and will then be used for a 3 month home trial, followed by outcomes testing. Group A then will cross over and train with their own Traditional Assistive Device and will then use their own device for a 3 month home trial, followed by outcomes testing.
Group II: Group BActive Control1 Intervention
Group B receives training in their own Traditional Assistive Device first; training will occur with their own Traditional Assistive Device and will then use their own device for a 3 month home trial, followed by outcomes testing. Group B then will cross over and receive the intervention Nomad KAFO; fitting & training will occur with the intervention and will then be used for a 3 month home trial, followed by outcomes testing.

Find a Location

Who is running the clinical trial?

Shirley Ryan AbilityLabLead Sponsor
194 Previous Clinical Trials
16,876 Total Patients Enrolled
1 Trials studying Paralysis
47 Patients Enrolled for Paralysis

Media Library

Indego Nomad® Powered Knee-Ankle-Foot Orthosis (Powered Orthosis) Clinical Trial Eligibility Overview. Trial Name: NCT05644522 — N/A
Paralysis Research Study Groups: Group A, Group B
Paralysis Clinical Trial 2023: Indego Nomad® Powered Knee-Ankle-Foot Orthosis Highlights & Side Effects. Trial Name: NCT05644522 — N/A
Indego Nomad® Powered Knee-Ankle-Foot Orthosis (Powered Orthosis) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05644522 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this study include those aged 50 and above in its participants?

"This clinical trial only accepts individuals aged 18 to 89; those younger or older will have 193 and 1581 separate studies available, respectively."

Answered by AI

Who is eligible to participate in this research initiative?

"This clinical trial seeks 36 participants between 18 and 89 years old, with spinal cord injuries. To be considered eligible for this research, they must also fulfil the following conditions: possess a unilateral or bilateral KAFO/SCO brace (or related device), demonstrate cognitive capability to comply with the study protocol; sign an informed consent form, and wear & charge a monitored activity tracker during 3 months of home trials."

Answered by AI

Are there any open enrollment opportunities for this research study?

"Unfortunately, according to the clinicaltrials.gov records, this particular trial is not presently accepting applicants. This experiment was initially posted on March 1st 2023 and last updated on February 21st 2023; however, there are 1880 other trials currently seeking participants."

Answered by AI
~24 spots leftby Dec 2027